The U.S. Food and Drug Administration (FDA) has updated its blood donation guidelines to remove a former ban related to concern about variant Creutzfeldt-Jakob disease (vCJD) transmission.
Medical laboratory professionals such as this pair at work at ARUP are in high demand. The U.S. Bureau of Labor Statistics estimated that nearly 26,000 more of these highly trained specialists will be needed each year through 2030.
Jennifer (Jenna) Rychert, PhD, ARUP medical director of Operational Informatics and Microbial Immunology, and Jonathan Genzen, MD, PhD, ARUP chief medical officer, coauthored the report of the new study, “Laboratory-Developed Test Orders in an Academic Health System.”
Tracy George, MD, ARUP president and chief scientific officer, is actively involved in efforts to encourage and help women and other underrepresented groups pursue careers in science, technology, engineering, and mathematics (STEM). ARUP’s efforts to offer mentorship and support in helping women to build their careers helped the company earn a spot on Forbes magazine’s Best Employers for Women list.
ARUP Laboratories is eighth in Utah on Forbes magazine’s list of America’s Best Employers By State, a testament to the good working environment ARUP maintains for all its employees, including for these specialists in the company’s Automated Core Lab.
In 2008, Megan Flipse started in ARUP's Exception Handling department in an entry-level role. Now, she oversees multiple departments as a Support Services group manager.
Mounting evidence suggests that kratom may lead to neonatal abstinence syndrome (NAS) in infants exposed to the substance in utero.
ARUP’s new autonomous intelligent vehicle (AIV) helps its coworkers in the lab by transporting specimens to storage, freeing up staff to focus on other tasks. Here, a team member unloads samples delivered by the AIV.
Kidneys perform critical functions within the body, and kidney impairment can lead to severe health consequences. ARUP’s adoption of a new equation to assess kidney function will enable better recognition and diagnosis of kidney disease in populations adversely affected by use of a previous equation.
Nathan Boggs, MD, PhD, an assistant professor of medicine at the Uniformed Services University who is engaged in systemic mastocytosis (SM) translational research, helped Mark Withers, MD, obtain a definitive diagnosis of SM after 20-plus years. Tracy George, MD, ARUP Laboratories president and chief scientific officer, has led the effort to develop highly sensitive tests at ARUP that aid in the diagnosis of SM and has played a key role in clinical trials for emerging treatments.
Lauren Pearson, DO, MPH, is the first appointed chief medical officer of ARUP at University of Utah Health. Her new role will support ARUP’s commitment to continuous quality improvement for clinical laboratory services across the University of Utah Health system.
ARUP Associate Medical Director Steven Baker, MD, PhD, will lead research that aims to determine whether gene therapies can be developed to treat patients living with creatine transporter deficiency (CTD).